These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

681 related items for PubMed ID: 9550290

  • 1. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
    Newman-Tancredi A, Verrièle L, Chaput C, Millan MJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):205-17. PubMed ID: 9550290
    [Abstract] [Full Text] [Related]

  • 2. S 14506: novel receptor coupling at 5-HT(1A) receptors.
    Milligan G, Kellett E, Dacquet C, Dubreuil V, Jacoby E, Millan MJ, Lavielle G, Spedding M.
    Neuropharmacology; 2001 Mar; 40(3):334-44. PubMed ID: 11166326
    [Abstract] [Full Text] [Related]

  • 3. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
    Gozlan H, Thibault S, Laporte AM, Lima L, Hamon M.
    Eur J Pharmacol; 1995 Jan 16; 288(2):173-86. PubMed ID: 7720779
    [Abstract] [Full Text] [Related]

  • 4. Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.
    Newman-Tancredi A, Verrièle L, Millan MJ.
    Br J Pharmacol; 2001 Jan 16; 132(2):518-24. PubMed ID: 11159702
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
    Khawaja X, Ennis C, Minchin MC.
    Life Sci; 1997 Jan 16; 60(9):653-65. PubMed ID: 9048968
    [Abstract] [Full Text] [Related]

  • 6. Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.
    Newman-Tancredi A, Conte C, Chaput C, Verrièle L, Audinot-Bouchez V, Lochon S, Lavielle G, Millan MJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun 16; 355(6):682-8. PubMed ID: 9205951
    [Abstract] [Full Text] [Related]

  • 7. S 15535 and WAY 100,635 antagonise 5-HT-stimulated [35S]GTP gamma S binding at cloned human 5-HT1A receptors.
    Newman-Tancredi A, Chaput C, Verrièle L, Millan MJ.
    Eur J Pharmacol; 1996 Jun 20; 307(1):107-11. PubMed ID: 8831111
    [Abstract] [Full Text] [Related]

  • 8. Agonist and inverse agonist efficacy at human recombinant serotonin 5-HT1A receptors as a function of receptor:G-protein stoichiometry.
    Newman-Tancredi A, Conte C, Chaput C, Verrièle L, Millan MJ.
    Neuropharmacology; 1997 Jun 20; 36(4-5):451-9. PubMed ID: 9225269
    [Abstract] [Full Text] [Related]

  • 9. Characterization of 5-HT1A receptor-mediated [35S]GTPgammaS binding in rat hippocampal membranes.
    Alper RH, Nelson DL.
    Eur J Pharmacol; 1998 Feb 19; 343(2-3):303-12. PubMed ID: 9570480
    [Abstract] [Full Text] [Related]

  • 10. Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin.
    Nénonéné EK, Radja F, Carli M, Grondin L, Reader TA.
    J Neurochem; 1994 May 19; 62(5):1822-34. PubMed ID: 8158133
    [Abstract] [Full Text] [Related]

  • 11. Nad-299 antagonises 5-HT-stimulated and spiperone-inhibited [35S]GTPgammaS binding in cloned 5-HT1A receptors.
    Jerning E, Rosqvist S, Mohell N.
    J Recept Signal Transduct Res; 2002 May 19; 22(1-4):483-95. PubMed ID: 12503636
    [Abstract] [Full Text] [Related]

  • 12. Correlation between low/high affinity ratios for 5-HT(1A) receptors and intrinsic activity.
    Assié MB, Cosi C, Koek W.
    Eur J Pharmacol; 1999 Dec 10; 386(1):97-103. PubMed ID: 10611469
    [Abstract] [Full Text] [Related]

  • 13. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
    Millan MJ, Canton H, Gobert A, Lejeune F, Rivet JM, Bervoets K, Brocco M, Widdowson P, Mennini T, Audinot V.
    J Pharmacol Exp Ther; 1994 Jan 10; 268(1):337-52. PubMed ID: 8301575
    [Abstract] [Full Text] [Related]

  • 14. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
    Rydelek-Fitzgerald L, Teitler M, Fletcher PW, Ismaiel AM, Glennon RA.
    Brain Res; 1990 Nov 05; 532(1-2):191-6. PubMed ID: 2282513
    [Abstract] [Full Text] [Related]

  • 15. Characterisation of the binding of [3H]WAY-100635, a novel 5-hydroxytryptamine1A receptor antagonist, to rat brain.
    Khawaja X, Evans N, Reilly Y, Ennis C, Minchin MC.
    J Neurochem; 1995 Jun 05; 64(6):2716-26. PubMed ID: 7760052
    [Abstract] [Full Text] [Related]

  • 16. Photoaffinity labelling and solubilization on the central 5-HT1A receptor binding site.
    Gozlan H, Emerit MB, el Mestikawy S, Cossery JM, Marquet A, Besselievre R, Hamon M.
    J Recept Res; 1987 Jun 05; 7(1-4):195-221. PubMed ID: 2957498
    [Abstract] [Full Text] [Related]

  • 17. Resolution of multiple affinity states of 5-hydroxytryptamine-1A receptors labelled by [3H]-8-hydroxy-2-(di-n-propilamino) tetralin in rat hippocampal membranes.
    Pesce G, Hery F.
    Gen Pharmacol; 1996 Jun 05; 27(4):723-9. PubMed ID: 8853311
    [Abstract] [Full Text] [Related]

  • 18. Agonist properties of pindolol at h5-HT1A receptors coupled to mitogen-activated protein kinase.
    Millan MJ, Newman-Tancredi A, Duqueyroix D, Cussac D.
    Eur J Pharmacol; 2001 Jul 13; 424(1):13-7. PubMed ID: 11470255
    [Abstract] [Full Text] [Related]

  • 19. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain.
    Casanovas JM, Vilaró MT, Mengod G, Artigas F.
    J Neurochem; 1999 Jan 13; 72(1):262-72. PubMed ID: 9886078
    [Abstract] [Full Text] [Related]

  • 20. 5-HT(1A) receptor agonist-antagonist binding affinity difference as a measure of intrinsic activity in recombinant and native tissue systems.
    Watson J, Collin L, Ho M, Riley G, Scott C, Selkirk JV, Price GW.
    Br J Pharmacol; 2000 Jul 13; 130(5):1108-14. PubMed ID: 10882396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.